|
Delayed
Toronto S.E.
11:29:11 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 3.750 CAD | +0.54% |
|
+3.02% | +38.89% |
| 07-28 | BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | BioRem Q2 Net Earnings Rise to C$0.11 Per Share | MT |
Evolution of the Average Target: BioRem Inc.
Evolution of the Target Price: BioRem Inc.
Changes in Analyst Recommendations: BioRem Inc.
58aeee4d2babaf7.rkDZEt6Mb6tPltr97H4C_Ikdkph9owXt2JT-PJa7n-g.gwyRIbv6IZIYpK2vlU86jvow-u1FyE_Zl8yJDv_P3rrWeOkinM0B7R3x6g~7e673b6aaa89c4f8eaf618aa5d7e156e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +20.64% | |||
| +11.75% | |||||
| +5.15% | |||||
| +17.16% | |||||
| +12.89% | |||||
| +12.79% | |||||
| +17.17% | |||||
| +14.13% | |||||
| +15.69% | |||||
| +23.18% | |||||
| Average | +15.06% | |||||
| Weighted average by Cap. | +11.81% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.730CAD
Average target price
4.500CAD
Spread / Average Target
+20.64%
High Price Target
4.500CAD
Spread / Highest target
+20.64%
Low Price Target
4.500CAD
Spread / Lowest Target
+20.64%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- BRM Stock
- Consensus BioRem Inc.
Select your edition
All financial news and data tailored to specific country editions
